BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22036346)

  • 1. NGAL--from discovery to a new era of "acute renal disease" diagnosis?
    Haase M; Haase-Fielitz A
    Clin Biochem; 2011 May; 44(7):499-500. PubMed ID: 22036346
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying a biomarker for acute kidney injury: an illusory quest?
    Schortgen F; Brochard L
    Am J Respir Crit Care Med; 2011 Apr; 183(7):838-40. PubMed ID: 21471074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neutrophil gelatinase-associated lipocalin as a new diagnostic tool for acute kidney injury].
    El Housseini Y; Schmidtko J; Meier P
    Rev Med Suisse; 2013 Nov; 9(406):2101-6. PubMed ID: 24383284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictor of early diagnosis, diagnosis, or progression of acute kidney injury.
    Ralib AM; Pickering JW; Endre ZH
    Ann Emerg Med; 2011 Jan; 57(1):75-6. PubMed ID: 21183092
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic test for early detection of acute kidney injury.
    Hollmen M
    Expert Rev Mol Diagn; 2011 Jul; 11(6):553-5. PubMed ID: 21745008
    [No Abstract]   [Full Text] [Related]  

  • 7. New biomarkers of acute kidney injury: promise for the future but beware the lure of novelty.
    Kanagasundaram NS
    Crit Care Med; 2009 Feb; 37(2):766-7. PubMed ID: 19325379
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome.
    Ronco C; Cruz D; Noland BW
    Semin Nephrol; 2012 Jan; 32(1):121-8. PubMed ID: 22365170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGAL: an emerging biomarker of acute kidney injury.
    Ronco C
    Int J Artif Organs; 2008 Mar; 31(3):199-200. PubMed ID: 18373312
    [No Abstract]   [Full Text] [Related]  

  • 10. Early detection of acute kidney injury with neutrophil gelatinase-associated lipocalin.
    McCullough PA; El-Ghoroury M; Yamasaki H
    J Am Coll Cardiol; 2011 Apr; 57(17):1762-4. PubMed ID: 21511112
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
    Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for AKI improve clinical practice: no.
    Ostermann M; Joannidis M
    Intensive Care Med; 2015 Apr; 41(4):618-22. PubMed ID: 25387818
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
    Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
    Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.
    Liu Y; Li HX; Ying ZW; Guo JJ; Cao CY; Jia W; Yang HR
    Clin Lab; 2016; 62(1-2):155-63. PubMed ID: 27012045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
    McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
    Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of plasma neutrophil gelatinase-associated lipocalin in acute kidney injury.
    Pickering JW; Endre ZH
    Blood Purif; 2013; 35(4):295-302. PubMed ID: 23712081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using NGAL as an early diagnostic test of acute kidney injury.
    Smertka M; Chudek J
    Ren Fail; 2012; 34(1):130-3. PubMed ID: 22011215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil gelatinase-associated lipocalin in acute kidney injury.
    Makris K; Kafkas N
    Adv Clin Chem; 2012; 58():141-91. PubMed ID: 22950345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine.
    Buelow MW; Dall A; Regner K; Weinberg C; Bartz PJ; Sowinski J; Rudd N; Katzmark L; Tweddell JS; Earing MG
    Congenit Heart Dis; 2012; 7(5):441-7. PubMed ID: 22537138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.